We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Ultrasonography With Elastography in Skin Neoplasms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01259037
Recruitment Status : Completed
First Posted : December 13, 2010
Last Update Posted : November 6, 2017
Information provided by (Responsible Party):
Darius Mehregan, Wayne State University

Brief Summary:
This study will look at high frequency ultrasound as a medical imaging modality and apply it to skin lesions. Elastography is an ultrasonic method of looking at the hardness of an area. We will use this to try and differentiate between benign and cancerous skin lesions.

Condition or disease
Benign and Malignant Skin Neoplasms

Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Prospective
Study Start Date : January 2009
Primary Completion Date : June 30, 2011
Study Completion Date : October 29, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Skin Cancer
U.S. FDA Resources

Biospecimen Retention:   Samples With DNA
Skin biopsies of lesions imaged with ultrasound are processed for routine histology and retained.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
General dermatologic population from suburban referral clinic.

Inclusion Criteria:

  • Patients with skin lesions undergoing biopsy for diagnosis.

Exclusion Criteria:

  • Patients with skin lesions which do not require biopsy for diagnosis.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01259037

United States, Michigan
Wayne State University
Detroit, Michigan, United States, 48201
Sponsors and Collaborators
Wayne State University

Responsible Party: Darius Mehregan, Chairman of Dermatology, Wayne State University
ClinicalTrials.gov Identifier: NCT01259037     History of Changes
Other Study ID Numbers: Elastography1
First Posted: December 13, 2010    Key Record Dates
Last Update Posted: November 6, 2017
Last Verified: October 2017

Keywords provided by Darius Mehregan, Wayne State University:

Additional relevant MeSH terms:
Skin Neoplasms
Neoplasms by Site
Skin Diseases